Government of Canada Invests $4.5 Million in Scientific and Clinical Hub for Orphan Drug Development

By September 13, 2016 No Comments

AGADA is excited to continue collaborations with Dalhousie University researchers and clinicians at the IWK on this 5 year project focusing on enabling drug development for orphan diseases in Nova Scotia. As the industry partner, AGADA will contribute $1 Million dollars to this project through cash contributions and in-kind services.

CBC News – Rare Diseases ACOA